A cholesterol receptor protein called LDLR appears to be a key driver of neurotoxicity in sporadic ALS, per new research ...

In one tiny town, more than a dozen people were diagnosed with the rare neurodegenerative disease ALS. Why? I n March 2009, ...

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene ...

The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...

A patient who sustained aphasia due to amyotrophic lateral sclerosis has regained the ability to communicate after receiving a brain-machine interface implant, a hospital in Beijing announced on ...

With over 100 people in attendance, public safety officers on Team Kalamazoo competed against Ann Arbor's Fraser Wolverines ...

AMR officials raised concerns at a Harrisburg city council meeting, claiming calls meant for their ALS teams are being ...

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...

Cognixion is recruiting adults with ALS for a clinical trial testing BCI headset ONE Axon-R as a communication aid.

“Knowing that we have the gene, I really wanted to do this not just for me and my family, but for others who have this form ...

Cheng et al. identify a mitochondrial complex IV (CIV) deficiency in the brains of patients with sporadic amyotrophic lateral sclerosis (ALS). They demonstrate that defects in mitochondrial CIV ...

This prospective study aimed to evaluate the effects of electroacupuncture combined with Chinese herbal medicine on gut microbiota and metabolomics in ALS patients. Ten ALS patients were randomly ...